Wednesday, January 28, 2015 1:05:16 AM
It is my opinion that the higher expenditures of marketing compared to R&D is a function of need and timing. They have already spent the money needed to develop the technology and apply for the patent. The engineering firm that is building the prototype may have only been paid an initial pre-development fee and will probably be owed quite a bit more when the prototype is finished.
I would like to point out a couple things about the patent rights because there have been many theories on how blozf has come about the licensing and patents of the technology.
I have seen several posts that say blozf has an agreement with the Karolinska institute concerning the patenting and licensing of the technology.
As per my research. This is not correct.
The institute's research was put into the public domain and Cannabix Breathalyzer Inc. (not Cannabix Technologies Inc.) took that public domain knowledge and developed a process and device and was first to file for a patent based on that device.
There are actually two companies at play here. There is Cannabix Breathalyzer Inc. which is owned by Kal Mahli. He has a definitive North American licensing agreement with Cannabix Technologies Inc. (BLOZF) whereby blozf and only blozf can bring this product to market in any and all North American countries. Malhi is of course the president of blozf as well as being the owner of CBI. I believe this was structured as such to allow Malhi to license the technology to other companies on other continents.
I'm bringing this up to point out that blozf doesn't have to give a big chunk or any chunk of the revenue to the institute that did the initial research into the technology.
The other thing I would like to point out is that when I began investing in this company, I had a long phone discussion with the CEO Rav, and what struck me most is that he actually cautioned me against investing too heavily in this stock pre-prototype because of the inherent volatility of the market. What crook says that?
None that's who.
The reason two of the directors resigned IMO is due to the fact that they were brought on board when this company was primarily a mineral exploration company which is where their experience was centered. They simply were not needed in the company's current direction.
This company is for real.
The management is for real.
The technology is for real.
If the product is for real, everyone who is in this thing is gonna come out smelling like roses.
I'm willing to risk my considerable investment for the reward.
Recent BLOZF News
- Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • InvestorsHub NewsWire • 04/30/2024 12:53:40 PM
- Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • InvestorsHub NewsWire • 04/25/2024 12:52:01 PM
- Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • InvestorsHub NewsWire • 04/22/2024 12:49:29 PM
- Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • InvestorsHub NewsWire • 04/16/2024 12:52:49 PM
- Cannabix Quantifies Marijuana Breath Samples from Maryland Green Lab - Results Analyzed at North Louisiana Criminalistics Laboratory • InvestorsHub NewsWire • 01/18/2024 02:56:11 PM
- Shares Up on Patent Filing for Marijuana Breathalyzer • AllPennyStocks.com • 01/03/2024 07:00:00 PM
- Cannabix Technologies Files Patent for Proprietary Laboratory Drug Analysis Device • InvestorsHub NewsWire • 01/03/2024 02:30:21 PM
- Cannabix Technologies to Participate in Green Lab Held by Montgomery County Police Department (Maryland) • InvestorsHub NewsWire • 12/22/2023 01:46:36 PM
- Cannabix Completes Initial Electronics Testing on Contactless Alcohol Breathalyzer, Commences International Certification Plans • InvestorsHub NewsWire • 11/07/2023 02:09:46 PM
- Cannabix's MSBS Marijuana Breathalyzer Technology Advances Quantification of THC in Breath • InvestorsHub NewsWire • 10/03/2023 12:50:42 PM
- Cannabix Technologies Files Breath Sample Capture Patent and Detects Delta- 8 THC in Early Testing • InvestorsHub NewsWire • 08/04/2023 12:52:02 PM
- Cannabix's MSBS Marijuana Breathalyzer Technology Detects THC in Breath after Edibles Consumption • InvestorsHub NewsWire • 06/14/2023 12:55:03 PM
- Cannabix Technologies Files Contact-Free Breath Patent Application and Updates on Development and Certification Plans • InvestorsHub NewsWire • 05/03/2023 12:50:25 PM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM